The administration of S-Ketamine, a rapid and long-lasting antidepressant drug, reverses the reductions in expression and activity of hippocampal Rac1 and rescues CUMS-evoked LTP damage and depression-like behavior. This evidence concerns the gene RAC1 and depressive symptom measurement.